Human Microbiome Drugs Global Market Segmentation and key Players Analysis 2024

Pune, India, 14th February 2018: WiseGuyReports announced addition of new report, titled “Human Microbiome-based Drugs and Diagnostics: Global Markets”.

Pune , India - February 14, 2018 /MarketersMedia/ —

Report Scope:
The scope of the study includes the major microbiome-based drugs and diagnostics that are likely to be commercialized within the next eight years. Each product within each market is analyzed to determine its market status, market potential during the time period of 2018 to 2024. Microbiome intellectual property, investments and collaborations are discussed.

Influencing factors, industry structure, challenges facing the industry and patent status are discussed. BCC Research examines companies in the industry, corporate alliances and assay consumption by indication. We profile 25+ companies participating in this rapidly developing and evolving sector.

GET SAMPLE REPORT @ https://www.wiseguyreports.com/reports/2820056-human-microbiome-based-drugs-and-diagnostics-global-markets

Report Includes:
- An overview of the global markets for human microbiome-based drugs and diagnostics.
- Analyses of global market trends, with estimates from 2017, and projections of compound annual growth rates (CAGRs) through 2024.
- Coverage of areas and applications where these technologies are applicable, such as cancer, diabetes, allergic disorders, irritable bowel disorders, celiac disease, and other G.I. disorders.
- An in-depth look at macro-level trends affecting this sector.
- Market intelligence on the technologies and platforms currently being deployed to develop these drugs and diagnostics.
- Specific emphasis on the products in development for various diseases, including the specific forecasts for these products by disease and geography.
- A look at the current level of investments in the sector, intellectual property development, and future of this sector.

Key Players
4D PHARMA
AOBIOME LLC
AVIDBIOTICS INC.
AXIAL BIOTHERAPEUTICS
C3 JIAN INC.
CAELUS HEALTH
DA VOLTERRA
ELIGO BIOSCIENCES
ENTEROME BIOSCIENCES
EVELO BIOSCIENCES
EVOLVE BIOSYSTEMS
METABIOMICS
MICROBIOME THERAPEUTICS
ORIGIN SCIENCES LTD.
OSEL INC.
OXTHERA
REBIOTIX INC.
RITTER PHARMACEUTICALS
SECOND GENOME
SERES THERAPEUTICS
SYMBERIX
SYNLOGIC BIOTICS
SYNTHETIC BIOLOGICS
UBIOME INC.
VEDANTA BIOSCIENCES
VITHERA PHARMACEUTICALS

Table of Content: Key Points
Chapter 1 Introduction
Study Goals and Objectives
Reasons for Doing This Study
Intended Audience
Scope of Report
Information Sources
Methodology
Geographic Breakdown
Analyst's Credentials
Chapter 2 Summary and Highlights
Chapter 3 Microbiome Overview
Scientific Background
Human Microbiome in Health and Disease
Advances in Microbiome Research
Focus Areas for Microbiome-Based Drugs and Diagnostics
Microbiome-Based Drugs: Product Development Strategies
Current Challenges in Microbiome Drug Development
Human Microbiome Project
MetaHIT Consortium
Public Sector Initiatives in Microbiome Research
Key Goals of the Human Microbiome Project
Key Achievements of the Human Microbiome Project
Key Goals of MetaHIT Initiative
Chapter 4 Human Microbiome-Based Drugs Market
Cancer
Obesity
Type 2 Diabetes
Ulcerative Colitis and Crohn's Disease
…Continued

ACCESS REPORT @ https://www.wiseguyreports.com/reports/2820056-human-microbiome-based-drugs-and-diagnostics-global-markets

Get in touch:
LinkedIn: www.linkedin.com/company/4828928
Twitter: https://twitter.com/WiseGuyReports
Facebook: https://www.facebook.com/Wiseguyreports-1009007869213183/?fref=ts

Contact Info:
Name: Norah Trent
Email: sales@wiseguyreports.com
Organization: WISEGUY RESEARCH CONSULTANTS PVT LTD
Address: Office No. 528, Amanora Chambers
Phone: +1-646-845-9349

Source URL: https://marketersmedia.com/human-microbiome-drugs-global-market-segmentation-and-key-players-analysis-2024/300923

For more information, please visit http://www.wiseguyreports.com

Source: MarketersMedia

Release ID: 300923

Latest News

Technology companies, banks lead gains for US stocks

Feb 21, 2018

Gains in technology, banks and industrial companies drove U.S. stocks higher Wednesday as investors sized up the latest company earnings news. Consumer goods companies lagged the most. The latest gains put the market on track to recoup some of its losses from a day earlier. KEEPING SCORE: The Standard & Poor's 500 index rose 14 points, or 0.6 percent, to 2,731 as of 1:10 p.m. Eastern Time. The Dow Jones industrial average gained 110 points, or 0.4 percent, to 25,075. The Nasdaq added 53 points, or 0.7 percent, to 7,288. The Russell 2000 index of smaller-company stocks picked up 15...

Google's digital assistant branches out to Nest camera

Feb 21, 2018

SAN FRANCISCO — Google's voice-activated assistant is branching out to Nest's deluxe security camera in an expansion that may amplify the privacy concerns surrounding internet-connected microphones. The virtual assistant is being offered to owners of the Nest Cam IQ in a free update rolling out Wednesday. The move comes just two weeks after Nest moved back under Google's direct control after spending nearly 2 1/2 years as a separate company owned by the same parent, Alphabet Inc. The $300 Nest Cam will give Google another potentially valuable earhole in its battle with Amazon and Apple to build digital command centers...

Markets Right Now: Tech, banks, retailers lead stock gains

Feb 21, 2018

NEW YORK — The latest on developments in financial markets (all times local): 11:45 a.m. Gains in technology, banks and industrial companies are driving stocks higher in midday trading, making up some of the ground the market lost a day earlier. Facebook was up 2.8 percent Wednesday, JPMorgan Chase rose 1.6 percent and Amazon rose 1.8 percent. Advance Auto Parts jumped 10.6 percent after reporting better earnings than analysts were expecting. Extra Space Storage climbed 1.7 percent after its results also came in ahead of forecasts. The Standard & Poor's 500 index rose 19 points, or 0.7 percent, to 2,735....

Scientists in Germany improve malaria drug production

Feb 21, 2018

BERLIN — Scientists in Germany who developed a new way to make a key malaria drug several years ago said Wednesday they have come up with a technique to make the process even more efficient, which should increase global access and reduce the cost. The new procedure refines a method developed in 2012 at the Max Planck Institute to use the waste product from the production of artemisinin, which is extracted from a plant known as sweet wormwood, to produce the drug itself. That involved a new machine that could convert about 40 percent of the waste acid into artemisinin...

Turkey to develop unmanned tanks, president says

Feb 21, 2018

ANKARA, Turkey — Turkey's president says the country will develop unmanned tanks to minimize risks to soldiers in combat. Recep Tayyip Erdogan announced the plan Wednesday during a speech delivered at a conference on Turkey's five-year development plan. His comments came as Turkey's military is carrying out a cross-border offensive in Syria to clear a border enclave of Syrian Kurdish rebels. Erdogan said: "We need to be able to manufacture unmanned tanks and we will do this ... We are becoming a country that is catching this technology." The Turkish leader said that U.S. refusal to provide Turkey with drones...

About The Next Discovery

The Next Discovery is equipped with recent Science & Tech news to impart knowledge to individuals awaiting the future.

Contact us: sales@tndiscovery.com